Search Results - "Presti, C"

Refine Results
  1. 1

    Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer by King, Christopher R., Ph.D., M.D, Brooks, James D., M.D, Gill, Harcharan, M.D, Presti, Joseph C., M.D

    “…Purpose Hypofractionated radiotherapy has an intrinsically different normal tissue and tumor radiobiology. The results of a prospective trial of stereotactic…”
    Get full text
    Journal Article
  2. 2

    Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial by King, Christopher R., Ph.D., M.D, Brooks, James D., M.D, Gill, Harcharan, M.D, Pawlicki, Todd, Ph.D, Cotrutz, Cristian, Ph.D, Presti, Joseph C., M.D

    “…Purpose The radiobiology of prostate cancer favors a hypofractionated dose regimen. We report results of a prospective Phase II clinical trial of stereotactic…”
    Get full text
    Journal Article
  3. 3

    Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels: Analysis of the National Health and Nutrition Examination Survey by CHANG, Steven L, HARSHMAN, Lauren C, PRESTI, Joseph C

    Published in Journal of clinical oncology (01-09-2010)
    “…Previous studies suggest that some common medications alter prostate-specific antigen (PSA) levels. It remains unclear whether these reported medication…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database Study by FREEDLAND, Stephen J, ISAACS, William B, PLATZ, Elizabeth A, TERNS, Martha K, ARONSON, William J, AMLING, Christopher L, PRESTI, Joseph C, KANE, Christopher J

    Published in Journal of clinical oncology (20-10-2005)
    “…Prostate growth and differentiation are under androgenic control, and prior studies suggested that tumors that develop in hypogonadal men are more aggressive…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Electrically conductive hydrogel composites made of polyaniline nanoparticles and poly( N-vinyl-2-pyrrolidone) by Dispenza, C., Presti, C. Lo, Belfiore, C., Spadaro, G., Piazza, S.

    Published in Polymer (Guilford) (08-02-2006)
    “…A novel electrically conductive composite material, consisting of polyaniline (PANI) nanoparticles dispersed in a polyvinyl pyrrolidone (PVP) hydrogel, was…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series by Nevoux, Pierre, Ouzzane, Adil, Ahmed, Hashim U., Emberton, Mark, Montironi, Rodolfo, Presti Jr, Joseph C., Villers, Arnauld

    Published in BJU international (01-08-2012)
    “…What's known on the subject? and What does the study add? Much of our understanding of the pathological basis of prostate cancer comes from our analysis of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Upgrading and Downgrading of Prostate Needle Biopsy Specimens: Risk Factors and Clinical Implications by Freedland, Stephen J, Kane, Christopher J, Amling, Christopher L, Aronson, William J, Terris, Martha K, Presti, Joseph C

    Published in Urology (Ridgewood, N.J.) (01-03-2007)
    “…Objectives The prostate biopsy Gleason grade frequently differs from the radical prostatectomy (RP) grade. Given the critical role that needle biopsy plays in…”
    Get full text
    Journal Article
  14. 14

    Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy by Punnen, Sanoj, Freedland, Stephen J, Presti, Joseph C, Aronson, William J, Terris, Martha K, Kane, Christopher J, Amling, Christopher L, Carroll, Peter R, Cooperberg, Matthew R

    Published in European urology (01-06-2014)
    “…Abstract Background The University of California, San Francisco, Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S) score uses pathologic data from…”
    Get full text
    Journal Article
  15. 15

    Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection by Freedland, Stephen J, Platz, Elizabeth A, Presti, Jr, Joseph C, Aronson, William J, Amling, Christopher L, Kane, Christopher J, Terris, Martha K

    Published in The Journal of urology (01-02-2006)
    “…Obesity has been associated with lower serum testosterone, theoretically resulting in decreased PSA production. Obesity has also been associated with prostatic…”
    Get more information
    Journal Article
  16. 16

    The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial by Presti, Jr, J C, Chang, J J, Bhargava, V, Shinohara, K

    Published in The Journal of urology (01-01-2000)
    “…We define the optimal systematic biopsy regimen to detect carcinoma of the prostate. A total of 483 consecutive patients referred for an abnormal digital…”
    Get more information
    Journal Article
  17. 17

    Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy by Cooperberg, Matthew R., Freedland, Stephen J., Pasta, David J., Elkin, Eric P., Presti, Joseph C., Amling, Christopher L., Terris, Martha K., Aronson, William J., Kane, Christopher J., Carroll, Peter R.

    Published in Cancer (15-11-2006)
    “…BACKGROUND. The University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) is a novel preoperative index which predicts the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Obesity, Prostate-Specific Antigen Nadir, and Biochemical Recurrence After Radical Prostatectomy: Biology or Technique? Results from the SEARCH Database by Ho, Tammy, Gerber, Leah, Aronson, William J, Terris, Martha K, Presti, Joseph C, Kane, Christopher J, Amling, Christopher L, Freedland, Stephen J

    Published in European urology (01-11-2012)
    “…Abstract Background Obesity is associated with an increased risk of biochemical recurrence (BCR) after radical prostatectomy (RP). It is unclear whether this…”
    Get full text
    Journal Article
  20. 20

    Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread by Ricardo-Gonzalez, Roberto Rafael, Nguyen, Michael, Gokden, Neriman, Sangoi, Ankur R, Presti, Jr, Joseph C, McKenney, Jesse K

    Published in The Journal of urology (01-03-2012)
    “…Bladder plasmacytoid carcinoma is an invasive urothelial carcinoma subtype that is emphasized for its morphological overlap with plasma cells and metastatic…”
    Get more information
    Journal Article